Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Perez

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|July 17, 2016
Azilsartan in Patients With Mild to Moderate Hypertension Using Clinic and Ambulatory Blood Pressure MeasurementsAlfonso Perez, Charlie Cao
British Journal of Hospital Medicine (London, England : 2005)|May 10, 2006
Cutaneous T-cell lymphomaAlfonso Perez, Sean Whittaker
Journal of Clinical Hypertension (Greenwich, Conn.)|August 26, 2016
The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood PressureAlfonso Perez, Charlie Cao
Medicina (Kaunas, Lithuania)|July 29, 2023
Gene Identification in Inflammatory Bowel Disease via a Machine Learning ApproachGerardo Alfonso Perez, Raquel Castillo
Journal of Personalized Medicine|March 25, 2022
An Entropy Approach to Multiple Sclerosis IdentificationGerardo Alfonso Perez, Javier Caballero Villarraso
Contact Dermatitis|December 21, 2004
Occupational contact dermatitis from 2,4-dinitrofluorobenzeneAlfonso Perez, Shalini Narayan, Jane Sansom
Journal of Clinical Medicine|April 23, 2022
Neural Network Aided Detection of Huntington DiseaseGerardo Alfonso Perez, Javier Caballero Villarraso
Journal of Personalized Medicine|May 27, 2023
Epigenetic Signatures in HypertensionGerardo Alfonso Perez, Victor Delgado Martinez
Diabetes & Vascular Disease Research|November 25, 2005
Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetesAlfonso Perez, Mehmood Khan, Todd Johnson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 3, 2010
Effects of pioglitazone and metformin fixed-dose combination therapy on cardiovascular risk markers of inflammation and lipid profile compared with pioglitazone and metformin monotherapy in patients with type 2 diabetesAlfonso Perez, Randal Jacks, Vipin Arora, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Hypertension (Greenwich, Conn.)|July 17, 2016
Azilsartan in Patients With Mild to Moderate Hypertension Using Clinic and Ambulatory Blood Pressure MeasurementsAlfonso Perez, Charlie Cao
British Journal of Hospital Medicine (London, England : 2005)|May 10, 2006
Cutaneous T-cell lymphomaAlfonso Perez, Sean Whittaker
Journal of Clinical Hypertension (Greenwich, Conn.)|August 26, 2016
The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood PressureAlfonso Perez, Charlie Cao
Medicina (Kaunas, Lithuania)|July 29, 2023
Gene Identification in Inflammatory Bowel Disease via a Machine Learning ApproachGerardo Alfonso Perez, Raquel Castillo
Journal of Personalized Medicine|March 25, 2022
An Entropy Approach to Multiple Sclerosis IdentificationGerardo Alfonso Perez, Javier Caballero Villarraso
Contact Dermatitis|December 21, 2004
Occupational contact dermatitis from 2,4-dinitrofluorobenzeneAlfonso Perez, Shalini Narayan, Jane Sansom
Journal of Clinical Medicine|April 23, 2022
Neural Network Aided Detection of Huntington DiseaseGerardo Alfonso Perez, Javier Caballero Villarraso
Journal of Personalized Medicine|May 27, 2023
Epigenetic Signatures in HypertensionGerardo Alfonso Perez, Victor Delgado Martinez
Diabetes & Vascular Disease Research|November 25, 2005
Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetesAlfonso Perez, Mehmood Khan, Todd Johnson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 3, 2010
Effects of pioglitazone and metformin fixed-dose combination therapy on cardiovascular risk markers of inflammation and lipid profile compared with pioglitazone and metformin monotherapy in patients with type 2 diabetesAlfonso Perez, Randal Jacks, Vipin Arora, et al.
Pageof 7